REPORT ID 13512

Asia-Pacific Heparin Market Report 2017

Publish Date
21-Nov-17
Pages
111
Format
Electronic (PDF)

In this report, the Asia-Pacific Heparin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Heparin for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Heparin market competition by top manufacturers/players, with Heparin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Hepalink
    N.V.Organon?Aspen Pharmacare?
    Pfizer
    Opocrin
    Sanofi-Aventis
    Sandoz(Novartis)
    Leo
    King-friend Biochemical Pharmaceutical
    Changshan Biochemical Pharmaceutical
    Qianhong Biopharma
    Dongcheng Biochemicals
    Jiulong Biochemicals

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    UFH
    LMWH
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Thromboembolic Disease
    Disseminated Intravascular Coagulation
    Anticoagulation
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Heparin Market Report 2017
1 Heparin Overview
    1.1 Product Overview and Scope of Heparin
    1.2 Classification of Heparin by Product Category
        1.2.1 Asia-Pacific Heparin Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Heparin Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 UFH
        1.2.4 LMWH
        1.2.5 Others
    1.3 Asia-Pacific Heparin Market by Application/End Users
        1.3.1 Asia-Pacific Heparin Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Thromboembolic Disease
        1.3.3 Disseminated Intravascular Coagulation
        1.3.4 Anticoagulation
        1.3.5 Other
    1.4 Asia-Pacific Heparin Market by Region
        1.4.1 Asia-Pacific Heparin Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Heparin (2012-2022)
        1.5.1 Asia-Pacific Heparin Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Heparin Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Heparin Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Heparin Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Heparin Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Heparin Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Heparin (Volume and Value) by Type
        2.2.1 Asia-Pacific Heparin Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Heparin Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Heparin (Volume) by Application
    2.4 Asia-Pacific Heparin (Volume and Value) by Region
        2.4.1 Asia-Pacific Heparin Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Heparin Revenue and Market Share by Region (2012-2017)

3 China Heparin (Volume, Value and Sales Price)
    3.1 China Heparin Sales and Value (2012-2017)
        3.1.1 China Heparin Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Heparin Revenue and Growth Rate (2012-2017)
        3.1.3 China Heparin Sales Price Trend (2012-2017)
    3.2 China Heparin Sales Volume and Market Share by Type
    3.3 China Heparin Sales Volume and Market Share by Application

4 Japan Heparin (Volume, Value and Sales Price)
    4.1 Japan Heparin Sales and Value (2012-2017)
        4.1.1 Japan Heparin Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Heparin Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Heparin Sales Price Trend (2012-2017)
    4.2 Japan Heparin Sales Volume and Market Share by Type
    4.3 Japan Heparin Sales Volume and Market Share by Application

5 South Korea Heparin (Volume, Value and Sales Price)
    5.1 South Korea Heparin Sales and Value (2012-2017)
        5.1.1 South Korea Heparin Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Heparin Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Heparin Sales Price Trend (2012-2017)
    5.2 South Korea Heparin Sales Volume and Market Share by Type
    5.3 South Korea Heparin Sales Volume and Market Share by Application

6 Taiwan Heparin (Volume, Value and Sales Price)
    6.1 Taiwan Heparin Sales and Value (2012-2017)
        6.1.1 Taiwan Heparin Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Heparin Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Heparin Sales Price Trend (2012-2017)
    6.2 Taiwan Heparin Sales Volume and Market Share by Type
    6.3 Taiwan Heparin Sales Volume and Market Share by Application

7 India Heparin (Volume, Value and Sales Price)
    7.1 India Heparin Sales and Value (2012-2017)
        7.1.1 India Heparin Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Heparin Revenue and Growth Rate (2012-2017)
        7.1.3 India Heparin Sales Price Trend (2012-2017)
    7.2 India Heparin Sales Volume and Market Share by Type
    7.3 India Heparin Sales Volume and Market Share by Application

8 Southeast Asia Heparin (Volume, Value and Sales Price)
    8.1 Southeast Asia Heparin Sales and Value (2012-2017)
        8.1.1 Southeast Asia Heparin Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Heparin Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Heparin Sales Price Trend (2012-2017)
    8.2 Southeast Asia Heparin Sales Volume and Market Share by Type
    8.3 Southeast Asia Heparin Sales Volume and Market Share by Application

9 Australia Heparin (Volume, Value and Sales Price)
    9.1 Australia Heparin Sales and Value (2012-2017)
        9.1.1 Australia Heparin Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Heparin Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Heparin Sales Price Trend (2012-2017)
    9.2 Australia Heparin Sales Volume and Market Share by Type
    9.3 Australia Heparin Sales Volume and Market Share by Application

10 Asia-Pacific Heparin Players/Suppliers Profiles and Sales Data
    10.1 Hepalink
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Heparin Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Hepalink Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 N.V.Organon?Aspen Pharmacare?
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Heparin Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 N.V.Organon?Aspen Pharmacare? Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Pfizer
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Heparin Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Pfizer Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Opocrin
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Heparin Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Opocrin Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Sanofi-Aventis
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Heparin Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Sanofi-Aventis Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Sandoz(Novartis)
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Heparin Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Sandoz(Novartis) Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Leo
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Heparin Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Leo Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 King-friend Biochemical Pharmaceutical
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Heparin Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 King-friend Biochemical Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Changshan Biochemical Pharmaceutical
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Heparin Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Changshan Biochemical Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Qianhong Biopharma
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Heparin Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Qianhong Biopharma Heparin Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Dongcheng Biochemicals
    10.12 Jiulong Biochemicals

11 Heparin Manufacturing Cost Analysis
    11.1 Heparin Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Heparin

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Heparin Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Heparin Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Heparin Market Forecast (2017-2022)
    15.1 Asia-Pacific Heparin Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Heparin Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Heparin Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Heparin Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Heparin Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Heparin Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Heparin Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Heparin Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Heparin Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Heparin Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Heparin Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Heparin Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Heparin Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Heparin Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Heparin Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Heparin Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Heparin Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Heparin Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Heparin Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer